SAB Biotherapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $263 | $944 | $305 |
Gross Profit | -758 | -1,040 | -639 |
EBITDA | -6,220 | -2,964 | -21,834 |
EBIT | -7,242 | -4,949 | -22,778 |
Net Income | -7,335 | -5,025 | -22,856 |
Net Change In Cash | 263 | 944 | 305 |
Free Cash Flow | -7,839 | -11,046 | -13,514 |
Cash | 17,242 | 14,034 | 56,566 |
Basic Shares | 9,255 | 9,241 | 5,926 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $2,238 | $23,904 | $60,876 | $55,237 |
Gross Profit | -1,506 | 20,612 | 59,222 | 55,237 |
EBITDA | -38,133 | -15,121 | -11,711 | 21,135 |
EBIT | -41,878 | -18,413 | -11,947 | 20,586 |
Net Income | -42,193 | -18,740 | -17,444 | 20,117 |
Net Change In Cash | 2,238 | 23,904 | 60,876 | 55,237 |
Free Cash Flow | -25,316 | -7,185 | -7,185 | -2,726 |
Cash | 56,566 | 15,046 | 33,206 | 12,610 |
Basic Shares | 5,521 | 4,352 | 2,733 | 2,701 |
Earnings Calls
| Quarter | EPS |
|---|---|
2021-06-30 | -$0.12 |
2021-03-31 | -$0.02 |
2020-12-31 | -$0.02 |
2020-09-30 | $0.15 |
